EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Link between Abdominal Obesity Indices and the Progression of Liver Fibrosis: Insights from a Population-Based Study

María Teresa Julián iD, Ingrid Arteaga, Pere Torán-Monserrat iD, Guillem Pera iD, Alejandra Pérez-Montes de Oca iD, Irene Ruiz-Rojano, Elena Casademunt-Gras iD, Carla Chacón, Nuria Alonso

Nutrients · 23.05.2024 · 16 (11) · 1586

DOI: 10.3390/nu16111586 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, online erschienen am 23.05.2024. Verfasst von María Teresa Julián und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Nutrition, Hospital Germans Trias i Pujol, 08916 Badalona, Barcelona, Spain. Hauptthemen laut MEDLINE: Obesity, Abdominal, Liver Cirrhosis, Disease Progression, Body Mass Index. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There is currently no available information on the correlation between abdominal obesity indices and the risk of liver fibrosis progression. We aimed to investigate the relationship between the body mass index (BMI), waist circumference (WC), and the visceral adiposity index (VAI) with the progression of liver fibrosis. The study also evaluated the association between these indices and the prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) and liver fibrosis. A total of 1403 subjects participated in the cross-sectional and longitudinal population-based study. Liver stiffness was assessed via transient elastography, at baseline and follow-up (median: 4.2 years). The subgroup with dysglycemia was also analyzed. In the cross-sectional study, the highest quartile of VAI, BMI ≥ 30 kg/m2, and abdominal obesity showed significant associations with the prevalence of MASLD and liver fibrosis, as well as with fibrosis progression. However, VAI showed no association with MASLD incidence. Among the dysglycemic subjects, there was no observed association between VAI and the incidence of MASLD or the progression of fibrosis. In conclusion, the BMI, WC, and the VAI are associated with an increased risk of progression to moderate-to-advanced liver fibrosis in the general population. However, the VAI does not perform better than the BMI and WC measurement.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Obesity, AbdominalLiver CirrhosisDisease ProgressionBody Mass IndexWaist CircumferenceHumansMaleFemaleMiddle AgedCross-Sectional StudiesAdultLongitudinal StudiesPrevalenceRisk FactorsIntra-Abdominal FatAged

Stichwörter der Autor:innen

abdominal obesitybody mass index (BMI)liver fibrosismetabolic dysfunction-associated steatotic liver disease (MASLD)transient elastography (TE)visceral adiposity index (VAI)waist circumference (WC)

Autor:innen und Institutionen

  • Department of Endocrinology and Nutrition, Hospital Germans Trias i Pujol, 08916 Badalona, Barcelona, Spain.
  • Unitat de Suport a la Recerca (USR) Metropolitana Nord, Fundació Institut Universitari d'Investigació en Atenció Primària Jordi Gol i Gurina (IDIAP Jordi Gol), 08303 Mataró, Barcelona, Spain.
  • Grup de Recerca en Malalties Hepàtiques a l'Atenció Primària (GRemHAp), IDIAP Jordi Gol, USR Metro-Nord, 08303 Mataró, Barcelona, Spain.
  • Primary Healthcare Center Vall del Tenes, Gerència d'Àmbit d'Atenció Primària Metropolitana Nord, Institut Català de la Salut, 08186 Llicà d'Amunt, Barcelona, Spain.
  • Germans Trias i Pujol Research Institute (IGTP), 08916 Badalona, Barcelona, Spain.
  • Primary Healthcare Center Dr. Barraquer, Gerència d'Àmbit d'Atenció Primària Metropolitana Nord, Institut Català de la Salut, 08930 Sant Adrià del Besos, Barcelona, Spain.

ORCID-Profile: María Teresa Julián, Pere Torán-Monserrat, Guillem Pera, Alejandra Pérez-Montes de Oca, Elena Casademunt-Gras

Förderung

  • Instituto de Salud Carlos III

Zitieren

APA

Julián, M. T., Arteaga, I., Torán-Monserrat, P., Pera, G., Pérez-Montes de Oca, A., Ruiz-Rojano, I., Casademunt-Gras, E., Chacón, C., & Alonso, N. (2024). The Link between Abdominal Obesity Indices and the Progression of Liver Fibrosis: Insights from a Population-Based Study. Nutrients, 16(11), 1586. https://doi.org/10.3390/nu16111586

Vancouver

Julián MT, Arteaga I, Torán-Monserrat P, Pera G, Pérez-Montes de Oca A, Ruiz-Rojano I, et al. The Link between Abdominal Obesity Indices and the Progression of Liver Fibrosis: Insights from a Population-Based Study. Nutrients. 2024;16(11):1586. doi:10.3390/nu16111586

BibTeX
@article{Julin2024,
  author = {Julián, María Teresa and Arteaga, Ingrid and Torán-Monserrat, Pere and Pera, Guillem and Pérez-Montes de Oca, Alejandra and Ruiz-Rojano, Irene and Casademunt-Gras, Elena and Chacón, Carla and Alonso, Nuria},
  title = {The Link between Abdominal Obesity Indices and the Progression of Liver Fibrosis: Insights from a Population-Based Study},
  journal = {Nutrients},
  year = {2024},
  volume = {16},
  number = {11},
  pages = {1586},
  doi = {10.3390/nu16111586}
}
Kostenlos starten →